We are live on ! Find out more
TCON

TRACON Pharmaceuticals, Inc. Common Stock

Delisted

TCON was delisted on the 27th of June, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
OM
1
Opaleye Management
Massachusetts
$8.46M +$1.71M +26,831 +21%
IC
2
Ikarian Capital
Texas
$7.45M
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.91M -$13.5K -212 -0.6%
NMC
4
NEA Management Company
Maryland
$960K
Two Sigma Advisers
5
Two Sigma Advisers
New York
$920K -$114K -1,790 -10%
BlackRock
6
BlackRock
New York
$835K +$7.02K +110 +0.7%
LA
7
Linden Advisors
New York
$787K
BFM
8
Boothbay Fund Management
New York
$743K
Renaissance Technologies
9
Renaissance Technologies
New York
$584K -$306K -4,799 -31%
Two Sigma Investments
10
Two Sigma Investments
New York
$555K -$381K -5,969 -37%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$398K -$5.81K -91 -1%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$235K
JJ
13
Johnson & Johnson
New Jersey
$233K
State Street
14
State Street
Massachusetts
$202K
TI
15
Telemetry Investments
New York
$201K -$185K -2,900 -44%
DY
16
Dowling & Yahnke
California
$131K +$22.3K +350 +17%
Franklin Resources
17
Franklin Resources
California
$121K
ACM
18
ACT Capital Management
Pennsylvania
$79K
Citadel Advisors
19
Citadel Advisors
Florida
$60K -$46.8K -734 -40%
Acadian Asset Management
20
Acadian Asset Management
Massachusetts
$55K +$20.5K +322 +46%
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$55K +$62.9K +986 New
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$54K -$9.7K -152 -13%
CL
23
CSS LLC
Illinois
$52K +$12.3K +193 +26%
XSC
24
X-Square Capital
Puerto Rico
$50K
Northern Trust
25
Northern Trust
Illinois
$48K